Does the herpes simplex virus only infect those who engage in risky sexual behaviors? The CBCD answers a question from its October 2015 survey.

ROCHESTER, NY, UNITED STATES, November 6, 2015 /EINPresswire.com/ --

“Infected with the herpes virus (HSV-1 or HSV-2)? The CBCD recommends taking Gene-Eden-VIR or Novirin.” - Greg Bennett, CBCD

The Center for the Biology of Chronic Disease (CBCD)’s October 2015 survey found that 64% of participants had the false belief that only those who engage in “risky” sexual behavior get infected with genital herpes. The reality is that herpes virus infection is extremely common, and “anyone who has ever had sex can get genital herpes. It's not about being clean, dirty, good or bad – it's about being normal and sexually active.” (1) In other words, a genital herpes infection is not an indication of “sexually bad behavior.” With that said, the CBCD points out that some people do have a higher risk of infection.

“These people:

• Are female.
• Have had many sex partners.
• Had sex for the first time at a young age.
• Have (or had) another sexually transmitted infection.
• Have a weakened immune system due to a disease or medicine. (2)

The Center for the Biology of Chronic Disease (CBCD) recommends that anyone infected with a herpes virus take Gene-Eden-VIR or Novirin. The formula of these natural antiviral products was shown to reduce HSV symptoms in two separate post-marketing clinical studies that followed FDA guidelines. Additionally, it was designed to help the immune system target the latent form of the virus.

Click to learn more about herpes symptoms.

The formula of Gene-Eden-VIR and Novirin was tested by Hanan Polansky and Edan Itzkovitz from the CBCD. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the family of herpes viruses, including HSV-1 and HSV-2. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with (HSV-1 or HSV-2)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (3) The study authors also wrote that, “We observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (3)

Both products can be ordered online on the Gene-Eden-VIR and Novirin websites, here:

http://www.gene-eden-vir.com

and

http://www.novirin.com

Gene-Eden-VIR and Novirin are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinensis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR and Novirin are the only natural antiviral products on the market with published clinical studies that support their claims.

Note: Novirin shares the same formula as Gene-Eden-VIR. The difference between the two is that Novirin has higher quality and more expensive ingredients.

“Herpes simplex viruses spread from person to person through close contact. You can get a herpes simplex virus from touching a herpes sore. Most people, however, get herpes simplex from an infected person who does not have sores. Doctors call this “asymptomatic viral shedding.” (2)

What treatments are available for herpes infections?

“Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day.” (3) There are also the natural supplements Novirin and Gene-Eden-VIR, which have a formula that was designed to help the immune system target the herpes virus when it is in a latent form.

The CBCD reminds the public that Gene-Eden-VIR and Novirin are not a cure. However, two clinical studies, published in peer reviewed medical journals showed that their formula decreases symptoms in infected individuals. Specifically, the formula of Gene-Eden-VIR and Novirin was shown to safely and effectively reduce herpes symptoms. Additionally, it was designed to help the immune system target the latent virus.

“We recommend that individuals who are infected with a latent herpes virus, take Gene-Eden-VIR or Novirin.” – Greg Bennett, CBCD

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us Twitter on here: @HananPolansky

All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) The New Zealand Herpes Foundation - Herpes Myths vs Facts.
http://www.herpes.org.nz/patient-info/myths-vs-facts/

(2) American Academy of Dermatology - Herpes simplex: Who gets and causes.
https://www.aad.org/dermatology-a-to-z/diseases-and-treatments/e---h/herpes-simplex/who-gets-causes

(3) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

Greg Bennett
CBCD
585-250-9999
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.